EP 0686148 A4 19960207 - INHIBITORS OF HIV REVERSE TRANSCRIPTASE
Title (en)
INHIBITORS OF HIV REVERSE TRANSCRIPTASE
Title (de)
INHIBITOREN DER HIV INVERSEN TRANSCRIPTASE
Title (fr)
INHIBITEURS DE LA TRANSCRIPTASE INVERSE DU VIH
Publication
Application
Priority
- US 2192593 A 19930224
- US 9401694 W 19940215
Abstract (en)
[origin: WO9419321A1] Novel indole compounds inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
IPC 1-7
IPC 8 full level
A61K 31/40 (2006.01); A61K 31/4025 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/41 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/535 (2006.01); A61P 31/12 (2006.01); A61P 37/04 (2006.01); C07D 209/12 (2006.01); C07D 209/30 (2006.01); C07D 209/42 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 413/06 (2006.01); C07D 417/12 (2006.01); C07D 521/00 (2006.01)
CPC (source: EP KR)
A61K 31/40 (2013.01 - KR); A61P 31/12 (2017.12 - EP); A61P 37/04 (2017.12 - EP); C07D 209/12 (2013.01 - EP); C07D 209/30 (2013.01 - EP KR); C07D 209/42 (2013.01 - EP); C07D 231/12 (2013.01 - EP); C07D 233/56 (2013.01 - EP); C07D 249/08 (2013.01 - EP); C07D 401/06 (2013.01 - EP); C07D 401/12 (2013.01 - EP); C07D 403/12 (2013.01 - EP); C07D 405/06 (2013.01 - EP); C07D 405/12 (2013.01 - EP); C07D 413/06 (2013.01 - EP); C07D 417/12 (2013.01 - EP)
Citation (search report)
- [PX] EP 0530907 A1 19930310 - MERCK & CO INC [US]
- [PX] THERESA M. WILLIAMS ET AL.: "5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase", JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 9, 30 April 1993 (1993-04-30), WASHINGTON US, pages 1291 - 1294
- See references of WO 9419321A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9419321 A1 19940901; AU 6254294 A 19940914; BG 62089 B1 19990226; BG 99879 A 19960228; BR 9405737 A 19951205; CA 2156420 A1 19940901; CN 1119856 A 19960403; EP 0686148 A1 19951213; EP 0686148 A4 19960207; FI 953954 A0 19950823; FI 953954 A 19950823; HU 9502468 D0 19951030; HU T74614 A 19970128; JP H08507067 A 19960730; KR 960701010 A 19960224; NO 953308 D0 19950823; NO 953308 L 19951024; PL 175788 B1 19990226; PL 310410 A1 19951211
DOCDB simple family (application)
US 9401694 W 19940215; AU 6254294 A 19940215; BG 9987995 A 19950823; BR 9405737 A 19940215; CA 2156420 A 19940215; CN 94191586 A 19940215; EP 94909663 A 19940215; FI 953954 A 19950823; HU 9502468 A 19940215; JP 51911994 A 19940215; KR 19950703549 A 19950823; NO 953308 A 19950823; PL 31041094 A 19940215